AUS
NZ
UK
CA
USA
IND
Headline
- Eli Lilly: With its strong presence in pharmaceuticals and promising drug innovations, Eli Lilly is set for significant growth and stability.
- Walmart: The retail giant's broad market reach and consistent performance make it a reliable choice for long-term success.
- Value Potential: Both companies offer robust growth prospects and resilience in varying economic conditions.
While exact predictions for future stock performance remain uncertain, successful companies often deliver rewards over the long term. The selection of stocks that align with one's preferences and risk tolerance can significantly impact financial outcomes. Here are two notable names to consider for potential strong performance through 2030:
- Eli Lilly
Eli Lilly (NYSE:LLY) has been a cornerstone of the pharmaceutical industry since the 19th century. Recently, the company has gained attention for its contributions to diabetes and weight loss treatments, particularly through its glucagon-like peptide-1 (GLP-1) agonists. While Novo Nordisk’s Ozempic and Wegovy lead the market, Eli Lilly's Mounjaro and Zepbound also show strong potential. Tirzepatide, the active ingredient in these drugs, is expected to generate $27 billion in annual sales by the end of the decade, positioning it as a market leader.
In addition to diabetes care, Eli Lilly has made strides in other therapeutic areas, including cancer and immunology. The approval of Kisunla, a treatment for early symptomatic Alzheimer's disease, underscores its commitment to innovative therapies. Kisunla has demonstrated a 35% reduction in cognitive and functional decline during late-stage trials, with sales projections reaching $2 billion by 2030.
Eli Lilly’s established portfolio includes long-standing successful drugs such as Verzenio, Taltz, and Jardiance. The company reported $6.1 billion in profits on $36 billion in revenue over the trailing 12 months. Known for its consistent dividend payments since 1885, Eli Lilly offers a dividend of $5.20 per share annually. Despite a lower yield, the stock has achieved a total return of approximately 700% over the past five years, with dividends increasing 100% during that period.
- Walmart
Walmart (NYSE:WMT) is renowned for its extensive network of stores and e-commerce presence. With over 10,000 locations worldwide and operations in 19 countries, Walmart is a leading retail force. The company's operations are divided into U.S. stores, international stores, and Sam's Club. Walmart’s U.S. operations include 162 distribution facilities and a robust e-commerce platform that integrates fulfillment centers and direct deliveries from stores.
As the world’s largest retailer, Walmart controls about 9% of U.S. retail sales. With 90% of the U.S. population living within 10 miles of a Walmart store, its commitment to low prices appeals to a broad customer base, enhancing its market stability.
Walmart’s recent financial performance reflects resilience despite challenging economic conditions. For the first quarter of fiscal 2025, the company reported $161.5 billion in revenue, a 6% increase from the previous year, and operating income of $6.8 billion, up 9.6%. Global e-commerce sales rose 21% year over year, and its advertising business grew by 24%.
Walmart is also known for its dependable dividend payments, having increased its dividend annually since 1974. The current dividend is under $1 annually, with a yield of around 1.2%, consistent with the average S&P 500 stock. The stock's total return over five years, factoring in capital gains and dividend growth, is around 100%. Despite a challenging retail environment, Walmart's strong financial health and commitment to dividends suggest continued potential for long-term success.
